Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
40.5%
% of HRTS's 42 holdings also in FMED
30.4%
% of FMED's 61 holdings also in HRTS
Overlap by Weight
Sector Drift (HRTS minus FMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in FMED |
Overlap | |
|---|---|---|---|---|
 |
UNITEDHEALTH GROUP INC | 6.1% | 4.1% | 4.1% |
|
BOSTON SCIENTIFIC CORP | 2.9% | 6.6% | 2.9% |
|
EDWARDS LIFESCIENCES CORP | 2.1% | 2.3% | 2.1% |
|
ALNYLAM PHARMACEUTICALS INC | 2.0% | 2.7% | 2.0% |
|
DANAHER CORP | 2.0% | 3.8% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to FMED
|
ELI LILLY & CO | 6.9% |
 |
NOVO NORDISK A/S-B | 4.2% |
|
BRIDGEBIO PHARMA, INC. | 4.2% |
 |
ASTRAZENECA PLC | 3.8% |
|
MERCK & CO. INC. | 3.5% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 3.4% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.1% |
|
ABBOTT LABORATORIES | 3.0% |
|
AMGEN INC | 2.7% |
|
VERTEX PHARMACEUTICALS INC | 2.6% |
HRTS Underweight Relative to FMED
|
INTUITIVE SURGICAL INC | -4.6% |
|
BOSTON SCIENTIFIC CORP | -3.7% |
 |
ARGENX SE ADR | -3.6% |
|
EXACT SCIENCES CORP | -3.2% |
|
PENUMBRA, INC. | -2.8% |
|
UCB SA | -2.8% |
|
STRYKER CORP | -2.7% |
|
INSULET CORP | -2.6% |
|
LIFESTANCE HEALTH GROUP, INC. | -2.6% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -2.3% |